You are here
Gigagen, Inc.
UEI: HF7MJJDVQQX5
# of Employees: 9
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Production Technology for Recombinant Intravenous Immunoglobulin
Amount: $3,000,000.00PROJECT SUMMARY Project TitleProduction Technology for Recombinant Intravenous Immunoglobulin OrganizationGigaGen IncPIDavid SJohnsonPh DIntravenous immunoglobulinor IVIgis a pool of antibodies isolat ...
SBIRPhase II2017Department of Health and Human Services National Institutes of Health -
Recombinant Hyperimmune Gammaglobulin for Primary Immunodeficiency
Amount: $1,499,857.00DESCRIPTION provided by applicant The Specific Aim of this SBIR direct to Phase II project is to develop natural repertoire recombinant intravenous immunoglobulin rIVIg andquot hyperimmunesandquot aga ...
SBIRPhase II2016Department of Health and Human Services National Institutes of Health -
Next-Generation Antibody Discovery and Development Technology
Amount: $1,570,238.00PROJECT SUMMARY Project TitleNext Generation Antibody Discovery and Development Technology OrganizationGigaGen IncPIDavid SJohnsonPh DDespite an enormous investment in novel therapiescancer still acco ...
SBIRPhase II2016Department of Health and Human Services National Institutes of Health -
Production Technology for Recombinant Intravenous Immunoglobulin
Amount: $225,000.00DESCRIPTION provided by applicant Production Technology for Recombinant IVIg Organization GigaGen Inc PI David S Johnson Ph D The Specific Aim of this SBIR Phase I project is to develop a natural repe ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Commercialization of an Advanced Technology for T Cell Receptor Analysis and Engineering
Amount: $265,000.00DESCRIPTION provided by applicant An Advanced Tool for T Cell Analysis Using Microfluidics Organization GigaGen Inc PI David S Johnson Ph D Better methods for discovery and monitoring of immune system ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Recombinant Hyperimmune Gammaglobulin for Pneumococcal Disease
Amount: $224,819.00DESCRIPTION provided by applicant Recombinant Hyperimmune Gammaglobulin for Pneumococcal Disease Organization GigaGen Inc PI David S Johnson Ph D The Specific Aim of this SBIR Phase I project is to ma ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
B Cell Repertoire Molecular Platform for Antibody Drug Discovery
Amount: $249,077.00DESCRIPTION (provided by applicant): Specific Aim of this Innovative Molecular Analysis Technologies (IMAT) SBIR Phase I grant proposal is to show the feasibility of a high-throughput molecular techno ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Therapeutic Antibody Discovery from Pancreatic Cancer B Cell Repertoires
Amount: $217,469.00DESCRIPTION (provided by applicant): The Specific Aim of this SBIR Phase I project is to build a technology for discovery of monoclonal antibody (mAb) drug candidates for pancreatic cancer from rare p ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Molecular Kits and Software for Lymphoid Malignancy Work-ups
Amount: $912,746.00DESCRIPTION provided by applicant The Specific Aim of this Phase II SBIR proposal is to develop four research use only RUO multiplexed molecular kits for comprehensive lymphoid malignancy pathology wo ...
SBIRPhase II2014Department of Health and Human Services National Institutes of Health -
Cloud-Based Bioinformatics for Immune Repertoire Analysis
Amount: $1,140,200.00DESCRIPTION provided by applicant The Specific Aim of this Phase II SBIR grant application is to launch ClonoByteandquot a website and cloud based platform for the processing storage analysis comparis ...
SBIRPhase II2013Department of Health and Human Services National Institutes of Health